rs762606868
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_017802.4(DNAAF5):c.1247T>C(p.Val416Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000312 in 1,603,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V416M) has been classified as Uncertain significance.
Frequency
Consequence
NM_017802.4 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 18Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF5 | NM_017802.4 | c.1247T>C | p.Val416Ala | missense_variant | Exon 5 of 13 | ENST00000297440.11 | NP_060272.3 | |
| DNAAF5 | XM_024446813.2 | c.1247T>C | p.Val416Ala | missense_variant | Exon 5 of 12 | XP_024302581.1 | ||
| DNAAF5 | NR_075098.2 | n.1207T>C | non_coding_transcript_exon_variant | Exon 5 of 13 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAAF5 | ENST00000297440.11 | c.1247T>C | p.Val416Ala | missense_variant | Exon 5 of 13 | 1 | NM_017802.4 | ENSP00000297440.6 | ||
| DNAAF5 | ENST00000440747.5 | c.650T>C | p.Val217Ala | missense_variant | Exon 5 of 13 | 2 | ENSP00000403165.1 | |||
| DNAAF5 | ENST00000437419.5 | c.563T>C | p.Val188Ala | missense_variant | Exon 4 of 5 | 5 | ENSP00000410788.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000375 AC: 9AN: 240018 AF XY: 0.0000535 show subpopulations
GnomAD4 exome AF: 0.0000296 AC: 43AN: 1450896Hom.: 0 Cov.: 32 AF XY: 0.0000347 AC XY: 25AN XY: 719990 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
This sequence change replaces valine with alanine at codon 416 of the DNAAF5 protein (p.Val416Ala). The valine residue is highly conserved and there is a small physicochemical difference between valine and alanine. This variant is present in population databases (rs762606868, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with DNAAF5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The c.1247T>C (p.V416A) alteration is located in exon 5 (coding exon 5) of the DNAAF5 gene. This alteration results from a T to C substitution at nucleotide position 1247, causing the valine (V) at amino acid position 416 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at